☆ 4.7 Article

ERRα promotes glycolytic metabolism and targets the NLRP3/caspase-1/GSDMD pathway to regulate pyroptosis in endometrial cancer

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2023)

Related references

Note: Only part of the references are listed.

Article Pharmacology & Pharmacy

Exosomal miR-211-5p regulates glucose metabolism, pyroptosis, and immune microenvironment of melanoma through GNA15

Bin Zeng et al.

Summary: Despite advances in cancer treatment, the prognosis for metastatic stage cancer patients remains poor due to the complexity of metastasis. This study demonstrates that a dry-lab-driven discovery approach combined with wet-lab validation can improve the efficiency of studying complex biological behaviors and yield more reliable mechanistic findings. Specifically, the study investigates the involvement of exosomal miRNAs in transferring metastatic capability between heterogeneous melanoma cancer cells and identifies key genes and mechanisms involved.

PHARMACOLOGICAL RESEARCH (2023)

Add to Collection

Article Oncology

Lipid reprogramming induced by the TFEB-ERRα axis enhanced membrane fluidity to promote EC progression

Xiaodan Mao et al.

Summary: This study reveals that lipid reprogramming induced by the TFEB-ERRα axis enhances the progression of endometrial cancer through EMT signaling. The TFEB-ERRα axis increases membrane fluidity, promotes pseudopod formation, and enhances cell invasion. TFEB and ERRα are highly expressed in EC patients and correlated with EC progression. Furthermore, the TFEB-ERRα axis affects lipid metabolism by altering mitochondrial function.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Add to Collection

Article Oncology

Intracellular MUC20 variant 2 maintains mitochondrial calcium homeostasis and enhances drug resistance in gastric cancer

Lingfeng Fu et al.

Summary: This study reveals that high expression of MUC20v2 is associated with aggressive characteristics of signet ring cell carcinoma (SRCC) in gastric cancer. MUC20v2 promotes cell survival and chemoresistance by maintaining mitochondrial calcium levels and mitochondrial membrane potential.

GASTRIC CANCER (2022)

Add to Collection

Article Medicine, Research & Experimental

IGF2BP1-regulated expression of ERRα is involved in metabolic reprogramming of chemotherapy resistant osteosarcoma cells

Qing He et al.

Summary: Doxorubicin (Dox) is the standard treatment for osteosarcoma (OS), but drug resistance limits its effectiveness. This study investigated metabolic reprogramming and its regulation in Dox-resistant OS cells. The results showed increased ATP levels and altered metabolic profiles in Dox-resistant cells, which was associated with elevated expression of estrogen-related receptor alpha (ERR alpha). Mechanistic analysis revealed increased mRNA stability in chemoresistant cells, possibly due to methylation of the 3' untranslated region of ERR alpha mRNA by N-6-methyladenine, leading to recruitment of IGF2BP1 and increased mRNA stability. Knockdown of IGF2BP1 reversed the metabolic alterations and downregulated ERR alpha, indicating the oncogenic role of the IGF2BP1/ERR alpha axis in Dox-resistant OS cells. Clinical analysis also showed correlation between IGF2BP1 and ERR alpha expression with OS progression.

JOURNAL OF TRANSLATIONAL MEDICINE (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Role of Pyroptosis in Gynecological Oncology and Its Therapeutic Regulation

Yi Huang et al.

Summary: With the advancement of molecular biotechnology, new cell death methods, including pyroptosis, have been discovered. Pyroptosis differs from apoptosis and autophagy in cell morphology and function. It is primarily mediated by intracellular inflammasome and gasdermin D of the gasdermin protein family, leading to the release of inflammatory factors. Pyroptosis has been found to be associated with infectious diseases, nervous system diseases, cardiovascular diseases, and even tumor cells. Therefore, exploring the impact of pyroptosis on tumors has become a research hotspot.

BIOMOLECULES (2022)

Add to Collection

Review Endocrinology & Metabolism

What role does pyroptosis play in cancer?

Chen Huang et al.

Summary: Pyroptosis, a caspase-dependent cell death, plays a complex role in cancer development. It can be both anti-tumor and pro-tumor. Pyroptosis provides potential new targets for cancer treatment and helps optimize the use of existing drugs. Immunotherapy is a hot research direction in the field of cancer treatment.

MOLECULAR METABOLISM (2022)

Add to Collection

Article Chemistry, Medicinal

Advantages of Tyrosine Kinase Anti-Angiogenic Cediranib over Bevacizumab: Cell Cycle Abrogation and Synergy with Chemotherapy

Jianling Bi et al.

Summary: The study aimed to compare the efficacy of cediranib and bevacizumab in endometrial cancer models. Results showed that cediranib blocked ligand-mediated ERK activation and promoted cell death when combined with chemotherapy, while neither bevacizumab nor cediranib alone had a significant effect on cell viability.

PHARMACEUTICALS (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Pyruvate kinase M2 (PKM2) interacts with activating transcription factor 2 (ATF2) to bridge glycolysis and pyroptosis in microglia

Mengmeng Li et al.

Summary: This study found that LPS can enhance glycolysis in microglia and that PKM2 plays a key role in this process. Silencing PKM2 or preventing its nuclear translocation can alleviate the LPS-induced inflammatory response and pyroptosis.

MOLECULAR IMMUNOLOGY (2021)

Add to Collection

Review Oncology

Pyroptosis: a new paradigm of cell death for fighting against cancer

Yixin Tan et al.

Summary: Pyroptosis is an inflammatory form of cell death with tumor suppressive function and the ability to evoke anti-tumor immune responses. Cancer therapies induce pyroptosis, enhancing anti-tumor immunity, but also leading to side effects on normal cells.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Add to Collection

Article Oncology

Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing

Jianling Bi et al.

Summary: The study successfully established patient-derived organoid models (PDOs) for endometrial and ovarian cancer, providing a personalized and predictive treatment option for gynecologic cancer patients. Drug sensitivity testing using PDOs can predict patient responses to specific therapies, guiding clinical treatment decisions effectively.

CANCERS (2021)

Add to Collection

Article Medicine, Research & Experimental

Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis

Hege F. Berg et al.

Summary: Researchers have successfully developed miniature tumor models of endometrial cancer directly from patient tumor tissue, which exhibit characteristics and responses similar to real tumors when implanted in mice. These models provide valuable tools for understanding the biology of endometrial tumors and potentially identifying new effective drugs for patients.

COMMUNICATIONS MEDICINE (2021)

Add to Collection

Article Oncology

Morphine-3-glucuronide upregulates PD-L1 expression via TLR4 and promotes the immune escape of non-small cell lung cancer

Kaiyuan Wang et al.

Summary: The study found that M3G can promote PD-L1 expression in NSCLC cells through the TLR4 pathway, affect the cytotoxicity of CTL through the PI3K signaling pathway, and thus promote tumor immune escape. Additionally, M3G can also promote tumor growth and metastasis.

CANCER BIOLOGY & MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Cisplatin Induces Pyroptosis via Activation of MEG3/NLRP3/caspase-1/GSDMD Pathway in Triple-Negative Breast Cancer

Honglin Yan et al.

Summary: The study revealed that cisplatin induces pyroptosis in triple-negative breast cancer cells through activation of the MEG3/NLRP3/caspase-1/GSDMD pathway, leading to its anti-tumor effects. This finding may contribute to the development of new therapeutic strategies for TNBC.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Add to Collection

Article Oncology

Clinical outcome of recurrent endometrial cancer: analysis of post-relapse survival by pattern of recurrence and secondary treatment

Francesco Legge et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)

Add to Collection

Review Medicine, Research & Experimental

Pyroptosis: A new frontier in cancer

Yuan Fang et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Add to Collection

Article Oncology

Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis

Jiao Feng et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)

Add to Collection

Review Oncology

Metabolic Symbiosis in Chemoresistance: Refocusing the Role of Aerobic Glycolysis

Lisi Ma et al.

FRONTIERS IN ONCOLOGY (2020)

Add to Collection

Review Oncology

Metabolic Plasticity in Chemotherapy Resistance

Maria Andrea Desbats et al.

FRONTIERS IN ONCOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Tanshinone II A enhances pyroptosis and represses cell proliferation of HeLa cells by regulating miR-145/GSDMD signaling pathway

Wenjuan Tong et al.

BIOSCIENCE REPORTS (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Targeting Hypoxia-Driven Metabolic Reprogramming to Constrain Tumor Progression and Metastasis

Marisol Miranda-Galvis et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Cell Biology

Cholesterol and Mevalonate: Two Metabolites Involved in Breast Cancer Progression and Drug Resistance through the ERRα Pathway

Matteo Brindisi et al.

CELLS (2020)

Add to Collection

Review Biology

The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression

Peter Vaupel et al.

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2019)

Add to Collection

Article Medicine, General & Internal

Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer

Daniela Matei et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Add to Collection

Article Biochemistry & Molecular Biology

A rectal cancer organoid platform to study individual responses to chemoradiation

Karuna Ganesh et al.

NATURE MEDICINE (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect

Linchong Sun et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)

Add to Collection

Article Oncology

Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer

Herve Tiriac et al.

CANCER DISCOVERY (2018)

Add to Collection

Article Oncology

ERRα suppression enhances the cytotoxicity of the MEK inhibitor trametinib against colon cancer cells

Sheng Zhou et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)

Add to Collection

Review Medicine, Research & Experimental

Role of HIF-1 in Cancer Progression: Novel Insights. A Review

Aldo Pezzuto et al.

CURRENT MOLECULAR MEDICINE (2018)

Add to Collection

Article Multidisciplinary Sciences

Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin

Yupeng Wang et al.

NATURE (2017)

Add to Collection

Article Oncology

MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer

Surendra K. Shukla et al.

CANCER CELL (2017)

Add to Collection

Article Multidisciplinary Sciences

Pore-forming activity and structural autoinhibition of the gasdermin family

Jingjin Ding et al.

NATURE (2016)

Add to Collection

Article Multidisciplinary Sciences

ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer

Genevieve Deblois et al.

NATURE COMMUNICATIONS (2016)

Add to Collection

Review Oncology

Hypoxia-Inducible Factors: Master Regulators of Cancer Progression

Luana Schito et al.

TRENDS IN CANCER (2016)

Add to Collection

Article Cell & Tissue Engineering

ERRs Mediate a Metabolic Switch Required for Somatic Cell Reprogramming to Pluripotency

Yasuyuki S. Kida et al.

CELL STEM CELL (2015)

Add to Collection

Article Oncology

Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death

Daniela Catanzaro et al.

ONCOTARGET (2015)

Add to Collection

Article Oncology

Cancer Statistics, 2014

Rebecca Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2014)

Add to Collection

Review Oncology

Endometrial cancer: A review and current management strategies: Part I

William M. Burke et al.

GYNECOLOGIC ONCOLOGY (2014)

Add to Collection

Article Oncology

ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells

Chang Zou et al.

JOURNAL OF PATHOLOGY (2014)

Add to Collection

Article Multidisciplinary Sciences

Inflammatory caspases are innate immune receptors for intracellular LPS

Jianjin Shi et al.

NATURE (2014)

Add to Collection

Review Medicine, Research & Experimental

HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations

Gregg L. Semenza

JOURNAL OF CLINICAL INVESTIGATION (2013)

Add to Collection

Review Oncology

Treatment options for advanced endometrial carcinoma

Don S. Dizon

GYNECOLOGIC ONCOLOGY (2010)

Add to Collection

Article Multidisciplinary Sciences

Involvement of estrogen-related receptors in transcriptional response to hypoxia and growth of solid tumors

Ada Ao et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.